NCT02303860View on ClinicalTrials.gov

Pharmacokinetic Study of Multiple Doses of ORM-12741 (Nebula PK 2)

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Healthy
Interventions
DRUG

ORM-12741 MR A

Modified release formulation of ORM-12741

DRUG

ORM-12741 MR B

Modified release formulation of ORM-12741

DRUG

ORM-12741 IR

Immediately release formulation of ORM-12741

Trial Locations (1)

02520

Clinical Research Services Turku - CRST Oy, Turku

All Listed Sponsors
lead

Orion Corporation, Orion Pharma

INDUSTRY

NCT02303860 - Pharmacokinetic Study of Multiple Doses of ORM-12741 (Nebula PK 2) | Biotech Hunter | Biotech Hunter